Skip to main content

Advertisement

SpringerLink
Log in

Prognostic significance of preoperative serum carcinoembryonic antigen in non-small cell lung cancer: a meta-analysis

  • Research Article
  • Published:
Tumor Biology

Abstract

Observational studies on the prognostic role of preoperative serum carcinoembryonic antigen (CEA) in non-small cell lung cancer (NSCLC) are controversial. Electronic databases updated until June 1, 2014 were searched to find relevant studies. A meta-analysis was conducted with eligible studies which quantitatively evaluated the relationship between preoperative serum CEA level and survival of patients with NSCLC. Survival data were aggregated and quantitatively analyzed. We performed a meta-analysis of 16 studies (n = 4,296 patients) that evaluated the correlation between preoperative serum CEA level and survival in patients with NSCLC. Combined hazard ratios suggested that preoperative serum CEA overexpression was associated with poor prognosis of overall survival (OS) (hazard ratio (HR) = 2.28, 95 % confidence interval (CI) 2.24–2.31) in patients with NSCLC. Meanwhile, for p-stage I NSCLC, the HR (95 % CI) was 1.98 (1.73–2.15). In the stratified analysis by patient source, significant risks were found among Asians and non-Asians. However, significant heterogeneity was observed among all studies. In the present meta-analysis, preoperative serum CEA overexpression indicates a poor prognosis for patients with NSCLC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277–300.

    Article  PubMed  Google Scholar 

  2. Molina JR, Yang P, Cassivi SD, et al. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83:584–94.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Alberg A, Ford J, Samet J. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines. Chest. 2007;132:29–55S.

    Article  Google Scholar 

  4. Paesmans M, Sculier JP, Libert P, et al. Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party. J Clin Oncol. 1995;13:1221–30.

    CAS  PubMed  Google Scholar 

  5. Donnem T, Bremnes RM, Busund LT, Andersen S, Pezzella F. Gene expression assays as prognostic and predictive markers in early stage non-small cell lung cancer. J Thorac Dis. 2012;4(2):212–3.

    PubMed Central  PubMed  Google Scholar 

  6. Osarogiagbon RU. Predicting survival of patients with resectable non-small cell lung cancer: beyond TNM. J Thorac Dis. 2012;4(2):214–6.

    PubMed Central  PubMed  Google Scholar 

  7. Hanagiri T, Sugaya M, Takenaka M, Oka S, Baba T, Shigematsu Y, et al. Preoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer. Lung Cancer. 2011;74(1):112–7.

    Article  PubMed  Google Scholar 

  8. Gold P, Freedman SO. Specific carcinoembryonic antigens of the human digestive system. J Exp Med. 1965;122:467.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Okada M, Nishio W, Sakamoto T. Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1 000 consecutive resections for clinical stage I disease. Ann Thorac Surg. 2004;78(1):216–21.

    Article  PubMed  Google Scholar 

  10. Lee JH, Chang JH. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer. Chest. 2005;128:2298.

    Article  PubMed  Google Scholar 

  11. N.I.H. Carcinoembryonic antigen: its role as a marker in the management of cancer. Br Med J. 1981;282:373.

    Article  Google Scholar 

  12. American Thoracic Society and European respiratory Society. Pretreatment evaluation of non-small-cell lung cancer. Am J Respir Crit Med. 1997;156:320.

    Article  Google Scholar 

  13. Altman DG. Systematic reviews of evaluations of prognostic variables. BMJ. 2001;323(7306):224–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815–34.

    Article  CAS  PubMed  Google Scholar 

  15. Yusuf S, Peto R, Lewis J, et al. Blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27:335–71.

    Article  CAS  PubMed  Google Scholar 

  16. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    Article  CAS  PubMed  Google Scholar 

  17. Egger M, Smith GD, Schneider M. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101.

    Article  CAS  PubMed  Google Scholar 

  19. Tomita M, Shimizu T, Ayabe T, Onitsuka T. Maximum SUV on positron emission tomography and serum CEA level as prognostic factors after curative resection for non-small cell lung cancer. Asia Pac J Clin Oncol. 2012;8(3):244–7.

    Article  PubMed  Google Scholar 

  20. Tomita M, Shimizu T, Ayabe T, et al. Prognostic significance of tumour marker index based on preoperative CEA and CYFRA 21-1 in non-small cell lung cancer. Anticancer Res. 2010;30(7):3099–102.

    CAS  PubMed  Google Scholar 

  21. Blankenburg F, Hatz R, Nagel D. Preoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer: external validation of a prognostic score. Tumour Biol. 2008;29(4):272–7.

    Article  CAS  PubMed  Google Scholar 

  22. Fukai R, Sakao Y, Sakuraba M. The prognostic value of carcinoem bryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung. Eur J Cardiothorac Surg. 2007;32(3):440–4.

    Article  PubMed  Google Scholar 

  23. Matsuoka K, Sumitomo S, Nakashima N. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer. Eur J Cardiothorac Surg. 2007;32(3):435–9.

    Article  PubMed  Google Scholar 

  24. Hsu WH, Huang CS, Hsu HS. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer. Ann Thorac Surg. 2007;83(2):419–24.

    Article  PubMed  Google Scholar 

  25. Tsuchiya T, Akamine S, Muraoka M. Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy. Lung Cancer. 2007;56(3):341–8.

    Article  PubMed  Google Scholar 

  26. Tomita M, Matsuzaki Y, Shimizu T. Relationship between serum carcinoembryonic antigen level and T status in non-small cell lung cancer. Anticancer Res. 2006;26(5B):3845–8.

    CAS  PubMed  Google Scholar 

  27. Muley T, Dienemann H, Ebert W. CYFRA 21-1 and CEA are independent prognostic factors in 153 operated stage I NSCLC patients. Anticancer Res. 2004;24(3b):1953–6.

    CAS  PubMed  Google Scholar 

  28. Niizeki H, Morikawa T, Okushiba S. Survival and prognostic factors in resected cN2-pN0 non-small cell lung cancer. Ann Thorac Cardiovasc Surg. 2004;10(1):9–13.

    PubMed  Google Scholar 

  29. Okada M, Sakamoto T, Nishio W. Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension. Cancer. 2003;98(3):535–41.

    Article  PubMed  Google Scholar 

  30. Sawabata N, Ohta M, Takeda S. Serum carcinoembryonic antigen level in surgically resected clinical stage I patients with non-small cell lung cancer. Ann Thorac Surg. 2002;74(1):174–9.

    Article  PubMed  Google Scholar 

  31. Suzuki K, Nagai K, Yoshida J. The prognosis of surgically resected N2 non-small cell lung cancer: the importance of clinical N status. J Thorac Cardiovasc Surg. 1999;118(1):145–53.

    Article  CAS  PubMed  Google Scholar 

  32. Graziano SL, Tatum AH, Newman NB. The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer. Cancer Res. 1994;54(11):2908–13.

    CAS  PubMed  Google Scholar 

  33. Steels E, Paesmans M, Berghmans T, et al. Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis. Eur Respir J. 2001;18:705–19.

    Article  CAS  PubMed  Google Scholar 

  34. Meert AP, Paesmans M, Martin B, et al. The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer. 2002;87:694–701.

    Article  PubMed Central  PubMed  Google Scholar 

  35. Meert AP, Martin B, Paesmans M, et al. The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature. Br J Cancer. 2003;89:959–65.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  36. Martin B, Paesmans M, Berghmans T, et al. Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer. 2003;89:55–64.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  37. Martin B, Paesmans M, Mascaux C, et al. Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis. Br J Cancer. 2004;91:2018–25.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  38. Mascaux C, Iannino N, Martin B, et al. The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer. 2005;92:131–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  39. Meert AP, Martin B, Delmotte P, et al. The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis. Eur Respir J. 2002;20:975–81.

    Article  CAS  PubMed  Google Scholar 

  40. Nakamura H, Kawasaki N, Taguchi M, et al. Survival impact of epidermal growth factor receptor overexpression in patients with non-small cell lung cancer: a meta-analysis. Thorax. 2006;61:140–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  41. Fan J, Wang L, Jiang GN, et al. The role of survivin on overall survival of non-small cell lung cancer, a meta-analysis of published literatures. Lung Cancer. 2008;61:91–6.

    Article  PubMed  Google Scholar 

  42. Begg CB, Berlin JA. Publication bias: a problem in interpreting medical data. J R Stat Soc A. 1988;151:419–63.

    Article  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Thoracic Cardiovascular Surgery, Inner Mongolia Forestry General Hospital, Yakeshi, China

    Xiao-Bin Wang

  2. Department of Oncology, Beijing Chest Hospital, Capital Medical University, Beijing, China

    Jie Li

  3. Department of Thoracic Surgery, Beijing Chest Hospital, Capital Medical University, No.97 Machang, Beijing, 101149, China

    Yi Han

Authors
  1. Xiao-Bin Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jie Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yi Han
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yi Han.

Additional information

Xiao-Bin Wang and Jie Li contributed equally to this work and should be considered as co-first authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, XB., Li, J. & Han, Y. Prognostic significance of preoperative serum carcinoembryonic antigen in non-small cell lung cancer: a meta-analysis. Tumor Biol. 35, 10105–10110 (2014). https://doi.org/10.1007/s13277-014-2301-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2301-6

Keywords

Search

Navigation